Evidence map›Paper›PMID 40332051›Full record

ReviewInternational journal of molecular sciences2025

Non-Integrin Laminin Receptors: Shedding New Light and Clarity on Their Involvement in Human Diseases.

Filomena Napolitano, Maria Fabozzi, Nunzia Montuori

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Filomena NapolitanoDepartment of Translational Medical Sciences, University of Naples Federico II, 80135 Naples, Italy.ORCID 0000-0003-1925-9912
Maria FabozziDepartment of Translational Medical Sciences, University of Naples Federico II, 80135 Naples, Italy.
Nunzia MontuoriDepartment of Translational Medical Sciences, University of Naples Federico II, 80135 Naples, Italy.ORCID 0000-0001-8697-986X

Funding

PRIN 2022 PNRR, Settore ERC: LS4 P2022HB33K - CUP: E53D23019850001
6 · The paper itself

Abstract

The extracellular matrix (ECM) is a dynamic network of macromolecules that provides structural support for cells and orchestrates cell signaling, functions, and morphology. The basement membrane constitutes a peculiar sheet-like type of ECM located between epithelial tissues and underlying connective tissues. The major constituent of the basement membrane is laminin, which exerts a remarkable repertoire of biological functions such as cell differentiation, migration, adhesion, and wound healing. Laminin performs its functions by interacting with two main classes of receptors, the integrin and the non-integrin laminin receptors, creating a complex network essential for tissue integrity and regeneration. Dysfunctional actions of laminin are the cause of diverse human diseases, including cancer, infectious, and neurodegenerative diseases. This topic has attracted researchers for some time, but the diversity of cell-surface receptors, through which laminin signaling occurs, makes the role of laminin controversial. Moreover, different laminin isoforms were identified, and each specific tissue basement membrane differs from the others in their laminin composition. This review focuses on the structural and molecular basis and pathophysiological relevance of specific interactions between laminins and non-integrin receptors in development, health, and disease.

Indexed as

LamininReceptors, LamininAnimalsBasement MembraneExtracellular MatrixHumansIntegrinsNeoplasmsSignal TransductionIntegrinsLamininReceptors, Lamininbasement membraneextracellular matrixlamininnon-integrin receptors

Identifiers

PMID40332051
PMCPMC12026610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.